RhumbLine Advisers’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $543K | Buy |
134,719
+52,533
| +64% | +$212K | ﹤0.01% | 2639 |
|
|
2025
Q1 | $224K | Sell |
82,186
-58,593
| -42% | -$160K | ﹤0.01% | 3053 |
|
|
2024
Q4 | $598K | Buy |
140,779
+7,037
| +5% | +$29.9K | ﹤0.01% | 2556 |
|
|
2024
Q3 | $393K | Buy |
133,742
+47,210
| +55% | +$139K | ﹤0.01% | 2870 |
|
|
2024
Q2 | $301K | Sell |
86,532
-2,599
| -3% | -$9.04K | ﹤0.01% | 3004 |
|
|
2024
Q1 | $254K | Sell |
89,131
-6,761
| -7% | -$19.3K | ﹤0.01% | 3057 |
|
|
2023
Q4 | $338K | Buy |
95,892
+10,065
| +12% | +$35.5K | ﹤0.01% | 2906 |
|
|
2023
Q3 | $222K | Sell |
85,827
-7,047
| -8% | -$18.3K | ﹤0.01% | 3099 |
|
|
2023
Q2 | $366K | Buy |
92,874
+8,832
| +11% | +$34.8K | ﹤0.01% | 2887 |
|
|
2023
Q1 | $284K | Buy |
84,042
+587
| +0.7% | +$1.98K | ﹤0.01% | 2632 |
|
|
2022
Q4 | $299K | Buy |
83,455
+1,992
| +2% | +$7.14K | ﹤0.01% | 2679 |
|
|
2022
Q3 | $328K | Sell |
81,463
-3,302
| -4% | -$13.3K | ﹤0.01% | 2690 |
|
|
2022
Q2 | $378K | Buy |
+84,765
| New | +$378K | ﹤0.01% | 2631 |
|